Bluejay Diagnostics, Inc. (BJDX) stock declined over -0.90% intraday to trade at $1.10 a share on NASDAQ. The stock opened with a loss of -0.00% at $1.09 and touched an intraday high of $1.14, falling -0.90% against the last close of $1.11. The stock went to a low of $1.05 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
IndustryHealth Care Equipment
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) stock price is $1.1 as of the last check on Thursday, June 23. During the trading session, BJDX stock reached the peak price of $1.14 while $1.05 was the lowest point it dropped to.
The NASDAQ listed BJDX is part of Health Care Equipment industry that operates in the broader Health Care sector. Bluejay Diagnostics, Inc. , a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States.
Mr. Indranil Dey
Pres, CEO & Director
Mr. Kenneth R. Fisher CPA
Chief Financial Officer
Dr. Jason Cook
Chief Technology Officer
Mr. Edwin Rule
VP of Regulatory, Quality & Compliance
BJDX stock traded closed the last session at $1.1, which is $-0.01 or -0.90% lower than its previous close of $1.11. BJDX's current trading price is 34.97% lower than its 52-week high of $6.25 where as its distance from 52-week low of 0.81% is -82.40%.
Number of BJDX employees currently stands at -. BJDX operates from 360 Massachusetts Avenue, Suite 203, Acton, MA 01720, United States.
Official Webiste of $BJDX is: https://www.bluejaydx.com
BJDX stock volume for the day was 86,058 shares while in the previous session number of BJDX shares traded was 86,400 . The average number of BJDX shares traded daily for last 3 months was 1.01 Million.
The percentage change in BJDX stock occurred in the recent session was -0.90% while the dollar amount for the price change in BJDX stock was $-0.01.
In the recent session, the day high for BJDX stock was $1.14 while the low for BJDX stock touched on the day was $1.05.
The market value of BJDX currently stands at 22 Million with its latest stock price at $1.1 and 20.14 Million of its shares outstanding.